By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Surgical Innovations Group plc

Surgical Innovations Group plc (SUN.L)

LSE Currency in GBP
£0.67
-£0.03
-4.13%
Last Update: 17 Jul 2025, 14:25
£6.26M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
£0.42 - £0.98
52 Week Range

SUN.L Stock Price Chart

Explore Surgical Innovations Group plc interactive price chart. Choose custom timeframes to analyze SUN.L price movements and trends.

There is nothing to show.

SUN.L Company Profile

Discover essential business fundamentals and corporate details for Surgical Innovations Group plc (SUN.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

8 Dec 1988

Employees

80.00

CEO

David John Marsh

Description

Surgical Innovations Group plc, together with its subsidiaries, designs, develops, manufactures, and sells devices for use in minimally invasive surgery (SI) and precision engineering markets in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The company's SI Brand segment researches, develops, manufactures, and distributes SI branded minimally invasive devices. This segment also offers YelloPort Elite and YelloPort +plus laparoscopic port access systems; LogiRange resposable laparoscopic instrument systems; FastClamp laparoscopic clamping systems; and QuickRange single use laparoscopic instrumentation. Its OEM segment researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through own label or co-branding. This segment also provides design and development solutions for producing a final device; and researches, develops, manufactures, and sells minimally invasive technology products for precision engineering applications. The company's Distribution segment distributes medical products through Elemental Healthcare Ltd. It also designs and manufactures autologous blood products. It sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. Surgical Innovations Group plc was incorporated in 1988 and is based in Leeds, the United Kingdom.

SUN.L Financial Timeline

Browse a chronological timeline of Surgical Innovations Group plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 29 Sept 2025

Earnings released on 30 May 2025

EPS came in at -£0.00, while revenue for the quarter reached £5.77M.

Earnings released on 30 Sept 2024

EPS came in at -£0.00, while revenue for the quarter reached £6.18M.

Earnings released on 18 Apr 2024

EPS came in at -£0.00, while revenue for the quarter reached £6.36M.

Earnings released on 19 Sept 2023

EPS came in at -£0.00, while revenue for the quarter reached £5.65M.

Earnings released on 29 Mar 2023

EPS came in at £0.00, while revenue for the quarter reached £5.93M, missing expectations by -50.19%.

Earnings released on 31 Dec 2022

EPS came in at -£0.00, while revenue for the quarter reached £11.34M.

Earnings released on 31 Dec 2021

EPS came in at -£0.00, while revenue for the quarter reached £4.91M.

Earnings released on 30 Jun 2021

EPS came in at -£0.00, while revenue for the quarter reached £4.22M.

Earnings released on 31 Dec 2020

EPS came in at -£0.00, while revenue for the quarter reached £3.74M.

SUN.L Stock Performance

Access detailed SUN.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
SUN.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
SUN.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More